| Literature DB >> 26886854 |
Susanne M Schwarzmaier1,2,3, Ciaran de Chaumont1, Matilde Balbi1,2, Nicole A Terpolilli2, Christoph Kleinschnitz4, Andras Gruber5, Nikolaus Plesnila1,2,6.
Abstract
Microthrombus formation and bleeding worsen the outcome after traumatic brain injury (TBI). The aim of the current study was to characterize these processes in the brain parenchyma after experimental TBI and to determine the involvement of coagulation factor XI (FXI). C57BL/6 mice (n = 101) and FXI-deficient mice (n = 15) were subjected to controlled cortical impact (CCI). Wild-type mice received an inhibitory antibody against FXI (14E11) or control immunoglobulin G 24 h before or 30 or 120 min after CCI. Cerebral microcirculation was visualized in vivo by 2-photon microscopy 2-3 h post-trauma and histopathological outcome was assessed after 24 h. TBI induced hemorrhage and microthrombus formation in the brain parenchyma (p < 0.001). Inhibition of FXI activation or FXI deficiency did not reduce cerebral thrombogenesis, lesion volume, or hemispheric swelling. However, it also did not increase intracranial hemorrhage. Formation of microthrombosis in the brain parenchyma after TBI is independent of the intrinsic coagulation cascade since it was not reduced by inhibition of FXI. However, since targeting FXI has well-established antithrombotic effects in humans and experimental animals, inhibition of FXI could represent a reasonable strategy for the prevention of deep venous thrombosis in immobilized patients with TBI.Entities:
Keywords: 2-photon microscopy; anticoagulation; in vivo; microthrombi; traumatic brain injury
Mesh:
Substances:
Year: 2016 PMID: 26886854 PMCID: PMC5011628 DOI: 10.1089/neu.2015.4173
Source DB: PubMed Journal: J Neurotrauma ISSN: 0897-7151 Impact factor: 5.269